However, GCLC, GSS, and GPX1 protein levels appeared to be significantly up-regulated in the majority of the primary CD34+ AML specimen, suggesting an aberrant glutathione metabolism in AML progenitor cells, which is in agreement with Pei's report [34]. The gene discussed is GPX1; the disease is acute myeloid leukemia.